In MM, a recent study highlighted that higher CD71 in SEVs and LEVs from patients of MM vs. MGUS is a significant diagnostic and prognostic biomarker, and that increased CD40 in LEVs derived from MM patients is positively associated with standard and high-risk cytogenetics [78]. This evidence concerns the gene CD40 and Miyoshi myopathy.